Dr. Roberto is a trained neurophysiologist. She received her BA in biological sciences and her PhD in basic neuroscience from the University of Pisa, Italy. In 2001, Dr. Roberto joined Scripps Research in La Jolla, California as a postdoctoral fellow to study the neuroadaptations induced by alcohol in the amygdala, a brain region crucial in mediating the behavioral effects of acute and chronic alcohol consumption. In 2005, Dr. Roberto started her own laboratory at Scripps Research, where she has continued to identify how stress, neuroimmune signaling, alcohol and other drugs of abuse alter neuronal function and synaptic transmission in the brain. She is a professor in and the vice chair of the Department of Molecular Medicine at Scripps Research. She has received several awards including the Young Investigator Award from the RSA, the Presidential Early Career Award for Scientists and Engineers, which is the highest honor bestowed by the US government on outstanding scientists beginning their independent careers, the Jacob P. Waletzky Award from the Society for Neuroscience, and the Schimmel Endowed Family Chair. Dr. Roberto is well-published, she is the principal investigator of a NIAAA Merit Award and several NIH-sponsored grants. She serves as Associate Editor for Neuropharmacology. She collaborates with researchers throughout Europe and the US and advocates globally for the development of research and collaboration with international colleagues.
Dr. Schnabl is a trained gastroenterologist and physician-scientist. He received his MD degree from the University Freiburg in Germany. After finishing his residency in internal medicine, he completed a gastroenterology fellowship at Columbia University in New York City. He joined the Division of Gastroenterology at UC San Diego in 2008 and he is currently Professor of Medicine. He is staff physician and attending at the VA San Diego Medical Center in La Jolla and the UCSD Medical Center. He is the Director of the NIH-funded San Diego Digestive Diseases Research Center (SDDRC). His research focus is to understand the complex multi-directional interactions that occur between the gut microbiota and the liver. Dr. Schnabl has published extensively in such highly-regarded journals as Nature, Nature Communications, Cell Host & Microbe, Journal of Clinical Investigation and Proceedings of the National Academy of Sciences and he has authored multiple reviews and book chapters. Dr. Schnabl is the principal investigator of a VA Merit Award, several NIH, foundation and industry-sponsored grants. He serves as Associate Editor for Journal of Hepatology.
Henry R. Kranzler, M.D. is the Benjamin Rush Professor of Psychiatry and Director of the Center for Studies of Addiction at the University of Pennsylvania. Trained as a physician, psychiatrist, and clinical investigator, Dr. Kranzler’s research on the molecular genetics of alcohol and drug use disorders and their precision pharmacological treatment has been supported since 1987 by grants from the U.S. National Institutes of Health. He has authored more than 500 journal articles and 100 book chapters and edited nine books. Since 2014, Dr. Kranzler has served as the Editor of Alcoholism: Clinical and Experimental Research, the official journal of ISBRA and RSA.
Susumu Higuchi, MD, PhD, is a director emeritus of the National Hospital Organization Kurihama Medical and Addiction Center, and the director of the WHO Collaborating Centre for Research and Training on Sub-stance Use and Addictive Behaviours. He has been involved in many domestic and international scientific activities, including serving as president of both ISBRA and the Japanese Society of Alcohol-Related Prob-lems, and as congress president of ISBRA in 2018. Dr. Higuchi has written more than 300 peer-reviewed scientific papers, published in established international books and journals, and more than 700 papers in do-mestic books and journals. For several decades Dr. Higuchi has worked on alcohol and gambling policy and programs, and has served as chair or committee member on many Japanese governmental initiatives. He has also closely collaborated with WHO in the field of disorders due to substance use and addictive behaviours. Clinically, Dr. Higuchi has been a leading psychiatrist in the field of alcohol dependence and behavioral ad-dictions in Japan, particularly in relation to gaming and gambling disorders.
Helmut K. Seitz, MD is Professor of Medicine, Gastroenterology, and Alcohol Research at Ruprecht Karls University Heidelberg, Germany. At present, he runs the Centre of Liver- and Alcohol-Associated Diseases, Ethianum Clinic Heidelberg, Germany. Dr. Seitz was President of the European Society for Biomedical Research on Alcoholism (ESBRA) (2005-2013) and is presently Director of the Board of the International Society for Biomedical Research on Alcoholism (ISBRA) as chair of finance. Dr. Seitz is recipient of various awards including the Richtzenhain Prize of the German Cancer Research Centre (1984), the Hans Adolf-Krebs Award of the German Society of Nutrition (1988), the Hiromasha Ishii Memorial Award (2010) of ISBRA, and the European Alcohol Research Award 2013. Dr. Seitz was on the cover of Cancer Research 1991 and on the cover of the Journal of Oncology 1997 for his research on alcohol and cancer. Dr. Seitz is author and co-author of 473 original papers, editorials, reviews, and book chapters. He has published 12 books. Dr. Seitz’s major contribution in the field of alcohol research is the identification of mechanisms in alcohol-associated carcinogenesis and in the pathogenesis of alcoholic liver disease (ALD) including diagnostic approaches in ALD.
Rainer Spanagel studied biology at the Universities of Tübingen and Munich and pursued his early training in behavioural pharmacology and neurochemistry at the Max Planck Institute (MPI) in Martinsried. In 1990, he moved to the MPI of Psychiatry in Munich and became head of the addiction research group and was awarded a lectureship in Pharmacology and Toxicology. In 2000, he relocated to the Central Institute of Mental Health in Mannheim, a leading European institution for biological psychiatry, to become scientific director of the Institute of Psychopharmacology. Professor Spanagel has been awarded many scientific prizes, most notably the Sir Hans Krebs Award for his seminal gene x environment study in rodents, the James B. Isaacson Award he received in 2008 for his continuing achievements in alcohol research, and the Reinhardt Koselleck Award for innovation in neuroscience. He has published more than 350 articles and is Editor-in-Chief of Addiction Biology.